BEIJING, July 15, 2026 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that registrational phase III clinical study results of novel TYK2 (Tyrosine Kinase 2) inhibitor soficitinib (ICP-332) met the primary endpoint in patients with moderate-to-severe atopic dermatitis (AD). The Phase III study is a randomized, double-blind, placebo-controlled, multicenter registrational clinical trial designed to evaluate the efficacy, safety and tolerability of soficitinib in patients with moderate-to-severe AD. The study demonstrated that soficitinib achieved the primary endpoint with statistical significance and clinically meaningful improvement. In addition, multiple secondary endpoints were successfully met, demonstrating...

Independent CRO Successfully Reproduces ERNA-101 Combination Data in Larger Preclinical Study, Significantly Strengthening Confidence as Company Advances Toward IND  ERNA-101 Plus Anti-PD-1 Achieved Complete Tumor Clearance and Long-Term Survival in Two-Thirds of Treated Animals While No Complete Responses Were Observed in Any Monotherapy or Control Group IND Submission Planned for Q3 2026 with First-in-Human Phase 1 Trial Expected to Begin in Q4 2026 CAMBRIDGE, Mass., July 15, 2026 (GLOBE NEWSWIRE) — Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced compelling new preclinical data independently validating the anti-tumor activity of its lead cell therapy candidate, ERNA-101, in combination with PD-1 checkpoint inhibition. The...

TORONTO, July 15, 2026 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that its MRI-guided, AI-powered, Robotically-Driven and Incisionless TULSA Procedure™ will be highlighted in several presentations by leading physicians at the upcoming Society of Robotic Surgery (“SRS”) Annual Meeting to be held in Fort Lauderdale, FL, July 23-26, 2026.* MAIN CONGRESS SESSIONSReal-world Outcomes after MRI-guided Transurethral Ultrasound Ablation of the Prostate in a Multicenter Post-market Registry Xiaosong Meng, MD, PhD; UT Southwestern Medical Center, Dallas, TXJuly 24, 2026; 9:55:10:00 a.m. EDTCAPTAIN Randomized Controlled Trial of MRI-guided Transurethral Ultrasound Ablation (TULSA) vs. Radical Prostatectomy: Primary Safety OutcomesXiaosong Meng, MD, PhD;...

MONTREAL, July 15, 2026 (GLOBE NEWSWIRE) — Gildan Activewear Inc. (GIL; TSX and NYSE) will report its 2026 second quarter financial and operating results on Thursday, July 30, 2026. A press release will be issued before markets open, and a conference call is scheduled on that same day at 8:30 AM ET to discuss the Company’s results. Glenn J. Chamandy, Gildan’s President and Chief Executive Officer, Luca Barile, Executive Vice President, Chief Financial Officer, Chuck Ward, Executive Vice President, Chief Commercial Officer and Jessy Hayem, Senior Vice President, Head of Investor Relations and Global Communications, will participate in this call intended for financial analysts and institutional investors. The conference call can be accessed by dialing (800) 715-9871 (Canada & U.S.) or (646) 307-1963 (international) and entering...

Vancouver, British Columbia, July 15, 2026 (GLOBE NEWSWIRE) — NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce its maiden gold-antimony Mineral Resource Estimate (“MRE”) for the gold (“Au”) and antimony (“Sb”) Limo Butte Project (the “Project”, “Limo Butte”) in Nevada. NevGold CEO, Brandon Bonifacio, comments: “Our maiden, large-scale, oxide gold-antimony Mineral Resource Estimate is a monumental milestone in advancing our uniquely positioned Limo Butte Project in Nevada, as we have delivered on one of the largest, most strategic, antimony-gold resources in the United States. We have the potential to advance to a near-term antimony production scenario from the already mined material on surface, while we systematically advance the other deposits including Resurrection Ridge,...

NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (“IREN”) today announced the appointment of Eric Hammersley as Chief Information Security Officer. The appointment follows the recent additions of Kambiz Aghili as Chief Product Officer and Michael Nudelman as Chief Development Officer, as IREN continues to strengthen its senior leadership team and expand its AI Cloud platform across new markets and services. As Chief Information Security Officer, Mr. Hammersley will lead IREN’s security program across all three layers of its platform: data centers, compute and software. Mr. Hammersley brings more than two decades of experience securing cloud platforms and critical infrastructure. He joins from Nutanix, where he served as Vice President, Engineering and Chief Product Security Officer, responsible for security...

RICHMOND, Va., July 15, 2026 (GLOBE NEWSWIRE) — The Brink’s Company (NYSE:BCO), a leading global provider of cash and valuables management, digital retail solutions, and ATM managed services, will host a conference call on Wednesday, August 5, at 9:00 a.m. (EDT) to review second-quarter 2026 financial results, which will be released earlier that morning. The conference call can be accessed by calling 888-349-0094 (in the U.S.) or 412-902-0124 (international). Participants should join at least five minutes prior to the start of the call. Participants can pre-register at https://dpregister.com/sreg/10210013/1044abca2fb to receive a direct dial-in number for the call. The call also will be accessible via live webcast at https://event.choruscall.com/mediaframe/webcast.html?webcastid=tA72Sjv5. A replay of the call will be available...

ALACHUA, Fla. and TAMPA, Fla., July 15, 2026 (GLOBE NEWSWIRE) — Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will release financial results for the second quarter of 2026 on Wednesday, July 29, 2026. Axogen management will host an investment-community conference call and webcast at 8:00 a.m. ET following the release. Investors interested in participating in the conference call by phone may dial toll-free at (877) 407-0993 or use the direct dial-in number at (201) 689-8795. A live webcast, an archived replay, and presentation slides from the event are available on the Investors page of the company’s website at www.axogeninc.com. About AxogenAxogen (Nasdaq: AXGN) is focused on the science, development...

Not for distribution to U.S. newswire services or dissemination in the United States. TORONTO, July 15, 2026 (GLOBE NEWSWIRE) — Flagship Communities Real Estate Investment Trust (“Flagship” or the “REIT”) (TSX:MHC.U) (TSX:MHC.UN) today announced a cash distribution of US$0.0545 per REIT unit for the month of July 2026, representing US$0.654 per REIT unit on an annualized basis. Payments will be made on or about August 17, 2026, to unitholders of record as of the close of business on July 31, 2026. Distributions paid to Canadian unitholders (and other non-U.S. unitholders) generally will be subject to U.S. withholding tax. Unitholders should consult their own tax advisors for advice with respect to the tax consequences of receiving a distribution from the REIT in their own circumstance. About Flagship Communities Real Estate Investment...